StockData
Becton Dickinson & Co logo

Becton Dickinson & Co (BDX) stock

BDXNYSESurgical & Medical Instruments & ApparatusFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 13/3015% above fair value
$212.61−2.64 (-1.23%)

Close on Nov 10, 2026Market cap $57.91BP/E 64.2Yield 1.96%

Becton Dickinson & Co grew revenue 17.4% to $23.25B over the twelve months to Jun 30, 2026. Operating income rose 13.0% to $2.48B, moving the operating margin from 11.1% to 10.7%. Free cash flow was $3.20B, up 54.2% from a year earlier. At the latest close the market valued the company at $57.91B, 64.2 times its earnings.

Revenue
$23.25B
+17.4% vs. a year earlier
Operating income
$2.48B
+13.0% vs. a year earlier
Free cash flow
$3.20B
+54.2% vs. a year earlier
EPS, diluted
$3.31
-39.6% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026

Valuation

Market cap
$57.91B
P/E ratio
64.2
Price to sales
2.49
Price to book
2.37
Dividend yield
1.96%
Free cash flow yield
5.53%

Fundamentals

Revenue
$23.25B
Net income
$941.00M
EPS, diluted
$3.31
Free cash flow
$3.20B
Book value per share
$88.73
Diluted shares
275M

Trading

Next earnings
Feb 8, 2027 (estimated, before the open)
Previous close
$215.25
Open
$213.93
Day's range
$211.70 – $215.25
Volume
1,790,253
Average volume (20 days)
1,947,373
Index membership
S&P 500, Russell 1000, Russell 3000
Beta (5 years)
0.49
52-week range
$140.11 – $216.74
RSI (14 days)
71.4
Volatility (1 year)
31.4%
Relative volume
0.99×
WACC
6.7%

Index membership is inferred from the holdings of funds that track each index (VOO, IVV, SPYM, IWB, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2009, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 10, 2026. The S&P 500 is measured by the SPY fund.

PeriodBDXS&P 500DifferenceBDX per yearS&P 500 per year
1 month+15.7%-3.7%+19.4 pts
3 months+19.1%-2.7%+21.8 pts
Year to date+42.1%+10.8%+31.2 pts
1 year+52.6%+11.2%+41.4 pts
3 years+22.6%+76.5%−53.9 pts+7.0%+20.8%
5 years+23.3%+72.9%−49.6 pts+4.3%+11.6%
10 years+84.8%+304.8%−220.0 pts+6.3%+15.0%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$23.25B+17.4% YoY

Gross profit

$10.91B+23.7% YoY

Operating income

$2.48B+13.0% YoY

Net income

$941.00M-40.6% YoY

EPS, diluted

$3.31-39.6% YoY

Free cash flow

$3.20B+54.2% YoY
Reported periodTrailing twelve months

Press releases

Releases Becton Dickinson filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Becton Dickinson

Surgical & Medical Instruments & Apparatus

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Its operations encompass five primary business segments: Medical Essentials, Connected Care, BioPharma Systems, Interventional, and Life Sciences. The company provides solutions such as infusion systems, vascular access products, specimen collection devices, diagnostic instruments, cell analysis tools, and surgical and urological implants. BD serves a broad customer base that includes hospitals, clinics, healthcare professionals, life science researchers, clinical laboratories, pharmaceutical and biotechnology companies, blood banks, retail pharmacies, and consumers.

Company profile, executives and history

Becton Dickinson stock: common questions

What is Becton Dickinson's stock price?

BDX closed at $212.61 on Nov 10, 2026, down 1.23% on the day. Over the past 52 weeks it traded between $140.11 and $216.74.

What is Becton Dickinson's market cap?

Becton Dickinson was worth $57.91B at the close on Nov 10, 2026: the share price times the diluted shares outstanding.

What is BDX's P/E ratio?

BDX trades at 64.2 times earnings, based on diluted earnings per share of $3.31 over the twelve months to Jun 30, 2026.

How much revenue does Becton Dickinson make?

Becton Dickinson reported revenue of $23.25B for the twelve months to Jun 30, 2026, up 17.4% from a year earlier.

Does Becton Dickinson pay a dividend?

Yes. Becton Dickinson paid $4.16 per share over the last twelve months, a yield of 1.96% at the latest price, and has raised its annual dividend 15 years in a row.

When does Becton Dickinson report earnings next?

Becton Dickinson is expected to report Q1 FY2027 results on Feb 8, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.

How has BDX stock performed over the past year?

Including dividends, BDX returned +52.6% over the past year, against +11.2% for the S&P 500.

How many BDX shares are sold short?

8M shares were sold short at the latest FINRA report, 2.98% of the float, or 5.2 days of average trading volume.

Who are Becton Dickinson's competitors?

Companies most similar to Becton Dickinson by business, industry and size include BSX, BAX, MDLN, SYK, MMM.

See a number that looks wrong?